Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) Director Floyd F. Petersen sold 3,000 shares of Amphastar Pharmaceuticals stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $41.40, for a total value of $124,200.00. Following the completion of the sale, the director now directly owns 78,409 shares […]
Pediatric Diabetes Therapeutic MarketAccording to Future Market Insights (FMI), the worldwide Pediatric Diabetes Therapeutic Market is estimated to reach US$ 1633.8 million in 2024 and US$ 2612.4 million by 2034. The market is projected to rise at a CAGR of 4.8% from 2024 to 2034.Growing awareness among parents conc.
Needham & Company LLC reaffirmed their hold rating on shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) in a report released on Wednesday morning, Benzinga reports. A number of other equities research analysts also recently weighed in on AMPH. JPMorgan Chase & Co. began coverage on shares of Amphastar Pharmaceuticals in a research note on […]
Nations Financial Group Inc. IA ADV boosted its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 37.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,524 shares of the company’s stock after acquiring an additional 3,982 shares during the quarter. […]
Needham & Company LLC reissued their hold rating on shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. Other equities analysts have also recently issued reports about the company. JPMorgan Chase & Co. started coverage on Amphastar Pharmaceuticals in a research note on Tuesday, […]